Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
  • Payor
Campus
  • Payor

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Relationship Between LDL-C LLTs and Risk of Stroke

Relationship Between LDL-C LLTs and Risk of Stroke

Learn more
Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Learn more
VTE Prophylaxis in Surgical Patients

VTE Prophylaxis in Surgical Patients

Learn more
Odyssey outcomes - mortality

Odyssey outcomes - mortality

Learn more
Acute Medical Illness: Advanced Age Alone Predicts Venous Thromboembolism Similar to Existing Risk Assessment Models

Acute Medical Illness: Advanced Age Alone Predicts Venous Thromboembolism Similar to Existing Risk Assessment Models

Learn more
ESC Lp(a) in Clinical practice EAS Consensus statement

ESC Lp(a) in Clinical practice EAS Consensus statement

Learn more
Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early

Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early

Learn more
ESC/EAS 2019 international guidelines

ESC/EAS 2019 international guidelines

Learn more
Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Learn more
VTE Risk Assessment in Surgical Patients

VTE Risk Assessment in Surgical Patients

Learn more
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Learn more
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Learn more